CAR T cell therapy and beyond

1. Harnessing the thymus as an in vivo bioreactor for in vivo generation of naïve CAR T cells.
2. Targeted cancer therapy with CAR T cell-derived extracellular vesicles.

Nanotechnology Cancer Treatments

1. Combination of bispecific antibody therapy with NexImmune’s Artificial Immune Modulation (AIM) platform in multiple myeloma and AML.
2. Targeted cancer therapy using  a novel NF-kB inhibitor and a gold nanoparticle-based drug delivery system (collaboration with Stevens Institute of Technology).